New insights into different adipokines in linking the pathophysiology of obesity and psoriasis,Lipids in Health and Disease

当前位置： X-MOL 学术 › Lipids Health Dis. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

New insights into different adipokines in linking the pathophysiology of obesity and psoriasis
Lipids in Health and Disease ( IF 4.5 ) Pub Date : 2019-09-14 , DOI: 10.1186/s12944-019-1115-3
Yi Kong ₁ , Suhan Zhang ₁ , Ruifang Wu ₁ , Xin Su ₂ , Daoquan Peng ₂ , Ming Zhao ₁ , Yuwen Su ₁

Affiliation

Psoriasis is a chronic, systemic, hyper-proliferative immune-mediated inflammatory skin disease. The results of epidemiological investigations have shown that psoriasis affects around 2% of the general population worldwide, and the total number of psoriasis patients is more than 6 million in China. Apart from the skin manifestations, psoriasis has been verified to associate with several metabolic comorbidities, such as insulin resistance, diabetes and obesity. However, the underlying mechanism is still not elucidated. Adipocytes, considered as the active endocrine cells, are dysfunctional in obesity which displays increased synthesis and secretion of adipokines with other modified metabolic properties. Currently, growing evidence has pointed to the central role of adipokines in adipose tissue and the immune system, providing new insights into the effect of adipokines in linking the pathophysiology of obesity and psoriasis. In this review, we summarize the current understanding of the pathological role of adipokines and the potential mechanisms whereby different adipokines link obesity and psoriasis. Furthermore, we also provide evidence which identifies a potential therapeutic target aiming at adipokines for the management of these two diseases.

更新日期：2019-09-14

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>